levodopa has been researched along with nomifensine in 61 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (54.10) | 18.7374 |
1990's | 14 (22.95) | 18.2507 |
2000's | 9 (14.75) | 29.6817 |
2010's | 5 (8.20) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Bedard, P; Marsden, CD; Parkes, JD | 1 |
Bygdeman, M; Freedman, R; Gerhardt, G; Hoffer, BJ; Leenders, KL; Olson, L; Seiger, A; Strömberg, I; Young, D; Zerbe, GO | 1 |
Akiyama, Y; Itoh, A; Koshimura, K; Miwa, S; Ohue, T | 1 |
Bernardi, G; Calabresi, P; Mercuri, NB | 2 |
Aquilonius, SM; Bjurling, P; Bredberg, E; Hartvig, P; Långström, B; Tedroff, J | 1 |
Männistö, PT; Törnwall, M | 1 |
Abbate, GM; Nieduzak, TR; Schmidt, CJ; Taylor, VL | 1 |
Maj, J; Rogóz, Z; Skuza, G; Sowińska, H; Superata, J | 1 |
Långström, B | 1 |
Abercrombie, ED; Bonatz, AE; Zigmond, MJ | 1 |
Kruk, ZL; Millar, J; Stamford, JA | 1 |
Dahl, CB; Götestam, KG | 1 |
Becker, RE; Blitzer, RD | 1 |
Minagawa, F; Nakabayashi, H; Takeda, R | 1 |
Facchinetti, F; Genazzani, AR; Golinelli, S; Oltramari, P; Petraglia, F; Santoro, V; Volpe, A | 1 |
Kuhr, WG; May, LJ; Wightman, RM | 1 |
Goldstein, M; Lloyd, KG; Willigens, MT | 1 |
Bizière, K; Kan, JP; Roncucci, R; Wermuth, CG; Worms, P | 1 |
Abe, Y; Kisara, K; Tadano, T; Yonezawa, A | 1 |
Braz, S; Ferreira, TM; Silveira Filho, NG; Troncone, LR; Tufik, S | 1 |
Harvey, NS | 1 |
D'Antona, N; De Leo, V; Genazzani, AR; Gioffrè, WR; Mazzullo, G; Petraglia, F; Sardelli, S | 1 |
Cohen, O; Globus, M; Melamed, E; Rosenthal, J; Uzzan, A | 1 |
Jackson, DM; Jenkins, OF | 1 |
Alagna, S; Anania, V; Chiandussi, L; Deplano, A; Langer, M; Masala, A; Rovasio, PP | 1 |
Vertosick, FT | 1 |
Sandyk, R | 1 |
Domenici, L; Fiorentini, A; Maffei, L; Piccolino, M; Trimarchi, C | 1 |
Gonzalez, JP; Littler, ME; Sewell, RD | 1 |
Masturzo, P; Murialdo, G; Nappi, G; Polleri, A; Sances, G; Savoldi, F | 1 |
Kruk, ZL; Millar, J; Stamford, JA; Wightman, RM | 1 |
Benco, R; Ferrari, C; Mailland, F; Rampini, P; Romussi, M | 1 |
D'Antona, N; Danero, S; De Leo, V; Franchi, F; Genazzani, AR; La Marca, S; Pieroni, ML; Ricci, MG; Urbani, TM | 1 |
Agnoli, A; Baldassarre, M; D'Urso, R; Del Roscio, S; Falaschi, P; Frajese, G; Mearelli, S; Rocco, A; Ruggieri, S | 1 |
Benco, R; Caldara, R; Crosignani, PG; Ferrari, C; Rampini, P; Scarduelli, C | 1 |
Broekkamp, CL | 1 |
Camanni, F; Cocchi, D; De Leo, V; Genazzani, AR; Müller, EE; Murru, S | 1 |
Barbieri, C; Benco, R; Caldara, R; Crossignani, RM; Ferrari, C; Rampini, P; Testori, GP; Trezzi, R | 1 |
Faglia, G; Moriondo, P; Nissim, M; Travaglini, P | 1 |
Findley, LJ; Hanks, G; Park, DM; Sandler, M | 1 |
Lechin, F; van der Dijs, B | 1 |
Barbieri, C; Caldara, R; Crosignani, PG; Ferrari, C; Malinverni, A; Mattei, AM; Rocchetti, M | 1 |
Gayrard, V; Malpaux, B; Thiéry, JC; Tillet, Y | 1 |
De Klippel, N; Ebinger, G; Herregodts, P; Michotte, Y; Sarre, S | 1 |
Abercrombie, ED; Jackson, D; Zigmond, MJ | 1 |
Andersson, J; Arvidson, B; Edling, C; Hartvig, P; Hellman, B; Johansson, G; Långström, B; Valind, S | 1 |
Michael, AC; Peters, JL | 1 |
Campbell, JM; Davies, RW; Favor, G; Gilmore, DP; Growney, CA; Kennedy, AK; Payne, AP; Russell, D; Stone, TW | 1 |
Di Monte, DA; Langston, JW; Protell, P; Quik, M; Tan, LC; Togasaki, DM | 1 |
Barak, LS; Beaulieu, JM; Caron, MG; Gainetdinov, RR; Sotnikova, TD; Wetsel, WC | 1 |
Hnasko, TS; Kremer, EJ; Palmiter, RD; Robinson, S; Sotak, BN | 1 |
Chen, Y; Chong, SC; Cui, HF; Sheu, FS; Ye, JS | 1 |
Beal, MF; Bogdanov, M; Burke, RE; Geghman, K; Jackson-Lewis, V; Li, C; Li, Y; Liu, W; Oo, TF; Przedborski, S; Tang, Y; Wang, L; Zhou, C | 1 |
Dollé, F; Hantraye, P; Kirik, D; Lavisse, S; Ozgur, M; Rbah-Vidal, L; Sahin, G; Thompson, LH | 1 |
Freestone, PS; Lipski, J; Lloyd, JT; Martini, A; McDouall, A; Mercuri, NB; Sood, R | 1 |
3 review(s) available for levodopa and nomifensine
Article | Year |
---|---|
Design of molecules labeled with beta+ emitters for use in multitracer investigations using positron emission tomography.
Topics: Beta Particles; Humans; Isotope Labeling; Levodopa; Methionine; Neurotransmitter Agents; Nomifensine; Raclopride; Salicylamides; Spiperone; Tomography, Emission-Computed | 1990 |
[Differential diagnosis of hyperprolactinemia].
Topics: Adenoma; Bromocriptine; Diagnosis, Differential; Humans; Hyperprolactinemia; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin; Prolactin Release-Inhibiting Factors; Thyrotropin-Releasing Hormone | 1986 |
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Levodopa; Male; Mental Disorders; Nomifensine; Nortriptyline; Parkinson Disease; Personality; Psychotic Disorders; Serotonin; Tryptophan | 1986 |
4 trial(s) available for levodopa and nomifensine
Article | Year |
---|---|
Nomifensine in Parkinson's disease.
Topics: Adult; Aged; Carbidopa; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Placebos; Trihexyphenidyl | 1977 |
Prolactin changes after administration of agonist and antagonist dopaminergic drugs in puerperal women.
Topics: Amphetamine; Carbidopa; Dopamine; Dopamine Antagonists; Female; Humans; Levodopa; Nomifensine; Postpartum Period; Pregnancy; Prolactin; Receptors, Dopamine | 1987 |
Central nervous system and pituitary mechanisms in dopaminergic stimulation of growth hormone release in women.
Topics: Adolescent; Adult; Carbidopa; Central Nervous System; Dopamine; Female; Growth Hormone; Humans; Levodopa; Nomifensine; Pituitary Gland; Receptors, Dopamine | 1981 |
Positron emission tomography studies of healthy volunteers--no effects on the dopamine terminals and synthesis after short-term exposure to toluene.
Topics: Adult; Carbon Radioisotopes; Carboxy-Lyases; Dopamine; Exercise; Humans; Isotope Labeling; Levodopa; Male; Middle Aged; Nomifensine; Putamen; Solvents; Toluene; Tomography, Emission-Computed | 1997 |
54 other study(ies) available for levodopa and nomifensine
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Eighteen-month course of two patients with grafts of fetal dopamine neurons for severe Parkinson's disease.
Topics: Brain Tissue Transplantation; Contingent Negative Variation; Corpus Striatum; Dopamine; Female; Fetal Tissue Transplantation; Humans; Levodopa; Mesencephalon; Motor Activity; Nervous System; Neurons; Nomifensine; Parkinson Disease; Time Factors; Tomography, Emission-Computed | 1992 |
L-dopa administration enhances exocytotic dopamine release in vivo in the rat striatum.
Topics: Animals; Calcium Channel Blockers; Corpus Striatum; Dihydropyridines; Dopamine; Exocytosis; Levodopa; Male; Nomifensine; Potassium; Rats; Rats, Inbred Strains; Sodium Channels; Tetrodotoxin | 1992 |
Actions of levodopa on rat substantia nigra zona compacta neurons.
Topics: Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cocaine; Female; Levodopa; Male; Neurons; Nomifensine; Rats; Rats, Wistar; Substantia Nigra; Sulpiride | 1992 |
Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response.
Topics: Aged; Brain; Corpus Striatum; Dopamine; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Neurologic Examination; Nomifensine; Parkinson Disease; Radioligand Assay; Receptors, Dopamine; Tomography, Emission-Computed | 1992 |
Acute toxicity of three new selective COMT inhibitors in mice with special emphasis on interactions with drugs increasing catecholaminergic neurotransmission.
Topics: Amphetamine; Animals; Benzophenones; Carbidopa; Catechol O-Methyltransferase Inhibitors; Catecholamines; Catechols; Clorgyline; Convulsants; Desipramine; Drug Interactions; Lethal Dose 50; Levodopa; Male; Mice; Motor Activity; Nitriles; Nomifensine; Pentanones; Selegiline; Synaptic Transmission; Yohimbine | 1991 |
Dopamine uptake inhibition potentiates the effects of L-DOPA on rat substantia nigra zona compacta neurons.
Topics: Action Potentials; Amphetamine; Animals; Biological Transport; Cocaine; Dopamine; Dopamine Antagonists; Drug Synergism; Female; In Vitro Techniques; Levodopa; Male; Neurons; Neurotransmitter Uptake Inhibitors; Nomifensine; Rats; Rats, Inbred Strains; Substantia Nigra; Sulpiride | 1991 |
5-HT2 antagonists stereoselectively prevent the neurotoxicity of 3,4-methylenedioxymethamphetamine by blocking the acute stimulation of dopamine synthesis: reversal by L-dopa.
Topics: 3,4-Dihydroxyphenylacetic Acid; 3,4-Methylenedioxyamphetamine; Animals; Anti-Arrhythmia Agents; Brain; Corpus Striatum; Dopamine; Dose-Response Relationship, Drug; Drug Synergism; Haloperidol; Homovanillic Acid; Levodopa; Male; Nomifensine; Piperidines; Rats; Rats, Inbred Strains; Ritanserin; Serotonin Antagonists; Stereoisomerism; Time Factors | 1991 |
Behavioural and neurochemical effects of Ro 40-7592, a new COMT inhibitor with a potential therapeutic activity in Parkinson's disease.
Topics: Animals; Antipsychotic Agents; Benzophenones; Catalepsy; Catechol O-Methyltransferase; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Levodopa; Male; Mice; Motor Activity; Nitrophenols; Nomifensine; Parkinson Disease; Rats; Rats, Inbred Strains; Stereotyped Behavior; Tolcapone | 1990 |
Effects of L-dopa on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats.
Topics: Animals; Catecholamines; Corpus Striatum; Dialysis; Dopamine; Extracellular Space; Hydroxydopamines; Levodopa; Male; Motor Activity; Nomifensine; Oxidopamine; Rats; Rats, Inbred Strains | 1990 |
Dissociation of the actions of uptake blockers upon dopamine overflow and uptake in the rat nucleus accumbens: in vivo voltammetric data.
Topics: Animals; Benztropine; Bupropion; Cocaine; Dopamine; Electric Stimulation; Electrochemistry; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Nucleus Accumbens; Piperazines; Propiophenones; Rats; Rats, Inbred Strains; Septal Nuclei | 1989 |
An open field study of antidepressant drugs.
Topics: Albuterol; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Behavior, Animal; Dibenzazepines; Dibenzocycloheptenes; Levodopa; Male; Motor Activity; Nomifensine; Piracetam; Piribedil; Rats; Rats, Inbred Strains; Viloxazine | 1989 |
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism.
Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Brain; Bromocriptine; Bupropion; Central Nervous System Stimulants; Cues; Generalization, Stimulus; Levodopa; Male; Nomifensine; Propiophenones; Rats; Receptors, Dopamine; Viloxazine | 1985 |
Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin.
Topics: Acetylcholine; Adult; beta-Endorphin; beta-Lipotropin; Blood-Brain Barrier; Bromocriptine; Dexamethasone; Domperidone; Dopamine; Humans; Levodopa; Male; Metoclopramide; Nomifensine; Reference Values | 1988 |
Differentiation of dopamine overflow and uptake processes in the extracellular fluid of the rat caudate nucleus with fast-scan in vivo voltammetry.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amphetamine; Animals; Benztropine; Bupropion; Caudate Nucleus; Dopamine; Electric Stimulation; Electrochemistry; Extracellular Space; Kinetics; Levodopa; Male; Microelectrodes; Neurotransmitter Uptake Inhibitors; Nomifensine; Piperazines; Propiophenones; Rats; Rats, Inbred Strains | 1988 |
Induction and reversal of dopamine dyskinesia in rat, cat, and monkey.
Topics: Animals; Apomorphine; Brain; Cats; Dextroamphetamine; Dopamine; Dose-Response Relationship, Drug; gamma-Aminobutyric Acid; Haplorhini; Humans; Levodopa; Motor Activity; Muscimol; Nomifensine; Piribedil; Rats; Receptors, Dopamine; Receptors, GABA-A; Stereotyped Behavior | 1985 |
SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Topics: 5-Hydroxytryptophan; Amphetamines; Animals; Antidepressive Agents; Behavior, Animal; Benzamides; Body Temperature; Catalepsy; Clorgyline; Drug Interactions; Female; Haloperidol; Imipramine; Levodopa; Male; Mice; Moclobemide; Monoamine Oxidase Inhibitors; Motor Activity; Nomifensine; Oxotremorine; Pargyline; Piperidines; Pyridazines; Rats; Rats, Inbred Strains; Reserpine; Selegiline; Stereotyped Behavior | 1987 |
Suppressive effects of intraventricular injected dopamine and nomifensine on muricide induced by thiamine deficiency.
Topics: Aggression; Animals; Apomorphine; Dopamine; Hydroxydopamines; Injections, Intraventricular; Levodopa; Male; Mice; Nomifensine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Thiamine Deficiency | 1987 |
Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
Topics: Aggression; Amphetamine; Animals; Apomorphine; Bromocriptine; Carbidopa; Dopamine; Imipramine; Levodopa; Male; Nomifensine; Rats; Rats, Inbred Strains; Sleep Deprivation; Sleep, REM; Stereotyped Behavior | 1988 |
Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Apomorphine; Bromocriptine; Corpus Striatum; Dopamine; Haloperidol; Levodopa; Male; Mice; Mice, Inbred C57BL; Nomifensine; Pyridines | 1985 |
Bromocriptine potentiates the behavioural effects of directly and indirectly acting dopamine receptor agonists in mice.
Topics: alpha-Methyltyrosine; Animals; Bromocriptine; Desipramine; Drug Synergism; Fluoxetine; Haloperidol; Levodopa; Male; Methyltyrosines; Mice; Motor Activity; Nomifensine; Receptors, Dopamine; Reserpine | 1985 |
Failure of nomifensine to reduce serum prolactin levels in patients with hepatic encephalopathy.
Topics: Adult; Estrogens; Hepatic Encephalopathy; Humans; Isoquinolines; Levodopa; Liver Cirrhosis; Male; Middle Aged; Nomifensine; Prolactin; Thyrotropin-Releasing Hormone | 1985 |
Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma.
Topics: Autoantibodies; Carbidopa; Dopamine; Female; Humans; Hypothalamo-Hypophyseal System; Levodopa; Metoclopramide; Monoiodotyrosine; Neural Inhibition; Nomifensine; Pituitary Neoplasms; Prolactin; Radioligand Assay; Receptors, Dopamine | 1985 |
Nomifensine in advanced parkinsonism.
Topics: Aged; Humans; Levodopa; Male; Nomifensine; Parkinson Disease | 1985 |
Dopaminergic drugs improve human visual contrast sensitivity.
Topics: Adult; Benserazide; Form Perception; Humans; Hydrazines; Levodopa; Nomifensine; Pattern Recognition, Visual | 1985 |
Stereoselective opiate antagonist induced hyperalgesia: evidence for a dopaminergic involvement.
Topics: Animals; Apomorphine; Dopamine; Injections, Intraventricular; Levodopa; Male; Mice; Naloxone; Narcotic Antagonists; Nomifensine; Pain; Tetrabenazine | 1982 |
Neuroendocrinological signs of central neurotransmission disorders.
Topics: Aging; Central Nervous System Diseases; Endocrine System Diseases; Headache; Humans; Levodopa; Neurotransmitter Agents; Nociceptors; Nomifensine; Periodicity; Prolactin | 1983 |
Striatal dopamine uptake in the rat: in vivo analysis by fast cyclic voltammetry.
Topics: Animals; Benztropine; Biomechanical Phenomena; Corpus Striatum; Dopamine; Electric Stimulation; Electrophysiology; Levodopa; Male; Medial Forebrain Bundle; Nomifensine; Rats; Rats, Inbred Strains | 1984 |
Effect of dihydroergocristine administration on serum prolactin and growth hormone levels in normal, hyperprolactinaemic, and acromegalic subjects: further evidence for pituitary dopamine deficiency in these conditions.
Topics: Acromegaly; Adenoma; Adolescent; Adult; Amenorrhea; Dihydroergotoxine; Dopamine; Female; Growth Hormone; Humans; Levodopa; Male; Middle Aged; Nomifensine; Pituitary Gland; Pituitary Neoplasms; Prolactin | 1983 |
[Various aspects of dopaminergic function in patients with prolactin-secreting hypophyseal adenoma].
Topics: Adenoma; Adult; Amenorrhea; Carbidopa; Dopamine; Female; Humans; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin | 1983 |
Presynaptic neuron and postsynaptic dopamine receptor function in long term treatment of Parkinson's disease: a neuroendocrine study.
Topics: Aged; Apomorphine; Benserazide; Bromocriptine; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease; Prolactin; Receptors, Dopamine; Selegiline; Tremor | 1980 |
Functional characterization of hypothalamic hyperprolactinemia.
Topics: Adult; Aged; Carbidopa; Child; Dopamine; Female; Humans; Hypothalamic Diseases; Levodopa; Male; Meningeal Neoplasms; Middle Aged; Nomifensine; Pituitary Neoplasms; Prolactin; Sulpiride; Thyrotropin-Releasing Hormone | 1982 |
Stereotypy and dyskinesias provoked in cats differentiate directly and indirectly-acting psychomotor stimulants.
Topics: Animals; Apomorphine; Cats; Dextroamphetamine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Nomifensine; Piribedil; Receptors, Dopamine; Stereotyped Behavior | 1982 |
Dynamic tests of prolactin secretion in hyperprolactinemic states: carbidopa-L-dopa and indirectly acting dopamine agonists.
Topics: Adenoma; Adult; Carbidopa; Dopamine; Female; Humans; Kinetics; Levodopa; Methylphenidate; Nomifensine; Pituitary Neoplasms; Postpartum Period; Pregnancy; Prolactin | 1982 |
Evaluation of two inhibitory tests (nomifensine and L-dopa + carbidopa) for the diagnosis of hyperprolactinaemic states.
Topics: Adenoma; Adolescent; Adult; Carbidopa; Diagnosis, Differential; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Pituitary Neoplasms; Polycystic Ovary Syndrome; Prolactin | 1980 |
Nomifensine: effect in Parkinsonian patients not receiving levodopa.
Topics: Aged; Double-Blind Method; Female; Humans; Isoquinolines; Levodopa; Male; Middle Aged; Nomifensine; Parkinson Disease | 1981 |
Physiological, clinical and therapeutical basis of a new hypothesis for headache.
Topics: Amphetamines; Autonomic Nervous System; Headache; Humans; Levodopa; Methylphenidate; Mianserin; Nomifensine | 1980 |
Effect of central nervous system dopaminergic activation on prolactin secretion in man: evidence for a common central defect in hyperprolactinemic patients with and without radiological signs of pituitary tumors.
Topics: Adolescent; Adult; Carbidopa; Female; Humans; Kinetics; Levodopa; Nomifensine; Pituitary Neoplasms; Prolactin | 1980 |
Estradiol increases tyrosine hydroxylase activity of the A15 nucleus dopaminergic neurons during long days in the ewe.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dialysis; Dopamine; Estradiol; Female; Homovanillic Acid; Hypothalamus; Levodopa; Luteinizing Hormone; Neurons; Nomifensine; Norepinephrine; Ovariectomy; Oxidopamine; Photoperiod; Sheep; Tyrosine 3-Monooxygenase | 1994 |
Biotransformation of locally applied L-dopa in the corpus striatum of the hemi-parkinsonian rat studied with microdialysis.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Benserazide; Biotransformation; Corpus Striatum; Denervation; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Homovanillic Acid; Levodopa; Male; Microdialysis; Nomifensine; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Tetrodotoxin | 1994 |
Impact of L-dopa on striatal acetylcholine release: effects of 6-hydroxydopamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Acetylcholine; Animals; Corpus Striatum; Dopamine; Extracellular Space; Levodopa; Male; Neurons; Nomifensine; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 1993 |
Changes in the kinetics of dopamine release and uptake have differential effects on the spatial distribution of extracellular dopamine concentration in rat striatum.
Topics: alpha-Methyltyrosine; Animals; Biological Transport; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Electric Stimulation; Enzyme Inhibitors; Kinetics; Levodopa; Male; Microelectrodes; Models, Chemical; Nomifensine; Rats; Rats, Sprague-Dawley | 2000 |
Pharmacological analysis of extracellular dopamine and metabolites in the striatum of conscious as/agu rats, mutants with locomotor disorder.
Topics: Amphetamine; Animals; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Extracellular Space; Levodopa; Male; Mice; Mice, Mutant Strains; Monoamine Oxidase Inhibitors; Movement Disorders; Nomifensine; Potassium; Reference Values | 2000 |
Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa.
Topics: Animals; Drug Combinations; Drug Synergism; Dyskinesia, Drug-Induced; Female; Levodopa; Nomifensine; Saimiri | 2005 |
Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease.
Topics: alpha-Methyltyrosine; Amphetamines; Animals; Antiparkinson Agents; Basal Ganglia; Blepharoptosis; Disease Models, Animal; Dopamine; Dopamine Agents; Dopamine Antagonists; Dopamine Plasma Membrane Transport Proteins; Female; Levodopa; Male; Mice; Motor Activity; Nomifensine; Norepinephrine; Parkinson Disease, Secondary; Phenotype; Piperazines; Tyrosine 3-Monooxygenase | 2005 |
Dysregulation of dopamine signaling in the dorsal striatum inhibits feeding.
Topics: Amphetamine; Animals; Apomorphine; Dopamine; Dopamine Agents; Dopamine Agonists; Dopamine Uptake Inhibitors; Eating; Feeding Behavior; Hypothalamus; Injections, Intraventricular; Levodopa; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Knockout; Neostriatum; Nomifensine; Signal Transduction; Tyrosine 3-Monooxygenase | 2005 |
Microelectrode array biochip: tool for in vitro drug screening based on the detection of a drug effect on dopamine release from PC12 cells.
Topics: Animals; Antipsychotic Agents; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Evaluation, Preclinical; Levodopa; Microarray Analysis; Microelectrodes; Nomifensine; PC12 Cells; Rats; Reserpine | 2006 |
Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease.
Topics: Age Factors; Animals; Antiparkinson Agents; Apomorphine; Brain; Chromosomes, Artificial, Bacterial; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Gene Transfer Techniques; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Levodopa; Mice; Mice, Transgenic; Movement Disorders; Mutation, Missense; Neurons; Nomifensine; Parkinson Disease; Protein Serine-Threonine Kinases | 2009 |
Differential dopamine receptor occupancy underlies L-DOPA-induced dyskinesia in a rat model of Parkinson's disease.
Topics: Animals; Benzamides; Disease Models, Animal; Dopamine; Dyskinesia, Drug-Induced; Extracellular Space; Female; Levodopa; Microdialysis; Neostriatum; Nomifensine; Parkinson Disease; Positron-Emission Tomography; Proto-Oncogene Proteins c-fos; Pyrrolidines; Rats, Sprague-Dawley; Receptors, Dopamine; Serotonin | 2014 |
Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta.
Topics: Animals; Dopaminergic Neurons; Inhibitory Postsynaptic Potentials; Levodopa; Membrane Potentials; Mice; Nomifensine; Quinolines; Substantia Nigra | 2019 |